Published in Proc Natl Acad Sci U S A on December 01, 1978
Autodigestion of lexA and phage lambda repressors. Proc Natl Acad Sci U S A (1984) 5.94
Effect of ssbA1 and lexC113 mutations on lambda prophage induction, bacteriophage growth, and cell survival. J Bacteriol (1980) 1.37
Synthesis of recA protein and induction of bacteriophage lambda in single-strand deoxyribonucleic acid-binding protein mutants of Escherichia coli. J Bacteriol (1980) 1.14
Escherichia coli single-strand DNA binding protein from wild type and lexC113 mutant affects in vitro proteolytic cleavage of phage lambda repressor. Proc Natl Acad Sci U S A (1982) 0.97
Ultraviolet light induction of recA protein in a recB uvrB mutant of Escherichia coli. J Bacteriol (1980) 0.89
Cobalt: an effector of E. coli recA protein activity. Nucleic Acids Res (1982) 0.77
Structural analysis of the carboxy terminus of bacteriophage lambda repressor determined by antipeptide antibodies. J Bacteriol (1989) 0.76
Serendipity. J Biol Chem (2008) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Nucleotide sequence of bacteriophage phi X174 DNA. Nature (1977) 95.69
Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol Rev (1976) 18.20
[Induction of the production of bacteriophages in lysogenic bacteria]. Ann Inst Pasteur (Paris) (1950) 16.57
Construction of plasmids carrying the cI gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1976) 13.10
T4 bacteriophage gene 32: a structural protein in the replication and recombination of DNA. Nature (1970) 10.87
Recombination between related temperate bacteriophages and the genetic control of immunity and prophage localization. Virology (1957) 7.00
A DNA-unwinding protein isolated from Escherichia coli: its interaction with DNA and with DNA polymerases. Proc Natl Acad Sci U S A (1972) 5.83
Proteolytic cleavage of bacteriophage lambda repressor in induction. Proc Natl Acad Sci U S A (1975) 5.16
DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol (1976) 4.65
Characterization by electron microscopy of the complex formed between T4 bacteriophage gene 32-protein and DNA. J Mol Biol (1972) 4.46
[System of repression insuring immunity in lysogenic bacteria]. C R Hebd Seances Acad Sci (1959) 3.84
Identification of the recA (tif) gene product of Escherichia coli. Proc Natl Acad Sci U S A (1977) 3.75
Identification and radiochemical purification of the recA protein of Escherichia coli K-12. Proc Natl Acad Sci U S A (1976) 3.64
Inactivation and proteolytic cleavage of phage lambda repressor in vitro in an ATP-dependent reaction. Proc Natl Acad Sci U S A (1977) 3.47
Primary structure of the lambda repressor. Biochemistry (1978) 2.73
Identification of protein X of Escherichia coli as the recA+/tif+ gene product. Mol Gen Genet (1977) 2.36
Enzymatic repair of DNA. Annu Rev Biochem (1975) 2.31
In vitro repression of RNA synthesis by purified lambda phage repressor. Nat New Biol (1971) 1.82
Inactivation of DNA-binding activity of repressor in extracts of lambda-lysogen treated with mitomycin C. Mol Gen Genet (1973) 1.46
Early events and mechanisms in the induction of bacterial SOS functions: analysis of the phage repressor inactivation process in vivo. Proc Natl Acad Sci U S A (1978) 1.32
Inactivation kinetics of lambda phage repressors in a mutant of E. coli temperature sensitive in DNA replication. Mol Gen Genet (1972) 1.21
Proposed mechanism of bacteriophage lambda induction: acquisition of binding sites for lambda repressor by DNA of the host. Proc Natl Acad Sci U S A (1975) 1.20
Prophage induction by high temperature in thermosensitive dna mutants lysogenic for bacteriophage lambda. J Virol (1973) 1.11
Induction of prophage lambda by gamma-rays, mitomycin C and tif; repressor cleavage studied by immunoprecipitation. Mol Gen Genet (1977) 0.94
Induction of recA+-protein synthesis in Escherichia coli. Mol Gen Genet (1978) 0.89
Correlation between UV dose requirement for lambda bacteriophage induction and lambda repressor concentration. J Virol (1978) 0.82
Induced radioresistance in four strains of Escherichia coli, two with lambda lysogens. Biophys J (1978) 0.82
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell (1980) 10.35
Two mRNAs can be produced from a single immunoglobulin mu gene by alternative RNA processing pathways. Cell (1980) 9.86
Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain. Cell (1980) 6.32
A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell (1981) 5.87
Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors. Science (1985) 4.28
An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99
Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science (1997) 2.93
Transcriptional enhancer elements in the mouse immunoglobulin heavy chain locus. Science (1983) 2.75
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. J Immunol (2000) 2.67
Mouse Cmu heavy chain immunoglobulin gene segment contains three intervening sequences separating domains. Nature (1980) 2.52
Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas. Science (1982) 2.40
Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science (1993) 2.40
An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res (1994) 2.32
Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev (1990) 2.31
Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol (2000) 2.24
Cultivation of Dictyostelium discoideum in axenic medium. Biochem Biophys Res Commun (1967) 2.24
An immunoglobulin promoter region is unaltered by DNA rearrangement and somatic mutation during B-cell development. Nucleic Acids Res (1982) 2.15
Yin-yang 1 activates the c-myc promoter. Mol Cell Biol (1993) 2.06
Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol (1991) 1.93
A transcriptional enhancer 3' of C beta 2 in the T cell receptor beta locus. Science (1988) 1.91
Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas. Proc Natl Acad Sci U S A (1982) 1.84
Multiple DNA sequence elements are necessary for the function of an immunoglobulin heavy chain promoter. Proc Natl Acad Sci U S A (1987) 1.80
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
Simian virus 40 agnoprotein facilitates normal nuclear location of the major capsid polypeptide and cell-to-cell spread of virus. J Virol (1986) 1.67
Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res (1993) 1.65
A dominant negative form of transcription activator mTFE3 created by differential splicing. Science (1991) 1.63
Development of a Pap smear quality-assurance system in family practice. Fam Med (1993) 1.60
Transcriptional regulation during B cell development. Annu Rev Immunol (1998) 1.52
mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol (1992) 1.49
A critical review of labor and birth care. Obstetrical Interest Group of the North American Primary Care Research Group. J Fam Pract (1991) 1.47
A transcriptional repressor of c-myc. Nature (1989) 1.41
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. 1980. J Immunol (2004) 1.40
In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer. Nucleic Acids Res (1988) 1.39
BLIMP-1: trigger for differentiation of myeloid lineage. Nat Immunol (2000) 1.39
The endogenous immunoglobulin heavy chain enhancer can activate tandem VH promoters separated by a large distance. Cell (1985) 1.39
Evidence that immunoglobulin VH-DJ recombination does not require germ line transcription of the recombining variable gene segment. Mol Cell Biol (1998) 1.38
Differential stability of c-myc mRNAS in a cell-free system. Mol Cell Biol (1988) 1.37
SV40 enhancer-binding factors are required at the establishment but not the maintenance step of enhancer-dependent transcriptional activation. Cell (1986) 1.32
Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res (1995) 1.30
Induction of prophage lambda without amplification of recA protein. Mol Gen Genet (1980) 1.24
Proteins binding to site C2 (muE3) in the immunoglobulin heavy-chain enhancer exist in multiple oligomeric forms. Mol Cell Biol (1989) 1.21
Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Mol Cell Biol (2000) 1.21
Construction and characterization of CV-1P cell lines which constitutively express the simian virus 40 agnoprotein: alteration of plaquing phenotype of viral agnogene mutants. J Virol (1986) 1.20
Proposed mechanism of bacteriophage lambda induction: acquisition of binding sites for lambda repressor by DNA of the host. Proc Natl Acad Sci U S A (1975) 1.20
Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest (1990) 1.16
Synthesis of recA protein and induction of bacteriophage lambda in single-strand deoxyribonucleic acid-binding protein mutants of Escherichia coli. J Bacteriol (1980) 1.14
Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res (1995) 1.14
Signaling pathways activated by oncogenic forms of Abl tyrosine kinase. J Biol Chem (1999) 1.13
The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold. J Clin Invest (1973) 1.13
v-Abl activates c-myc transcription through the E2F site. Mol Cell Biol (1995) 1.13
The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction. Mol Cell Biol (1994) 1.12
The absence of the transcription activator TFE3 impairs activation of B cells in vivo. Mol Cell Biol (1997) 1.12
Solitary pulmonary nodules. CT-bronchoscopic correlation. Chest (1988) 1.11
Papanicolaou smear quality assurance: providing feedback to physicians. J Fam Pract (1993) 1.11
Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases. Genes Dev (1997) 1.10
Physical characterization of deoxyribonucleic acids in Dictyostelium discoideum. Arch Biochem Biophys (1971) 1.10
The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro. J Immunol (1992) 1.10
Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol Cell Biol (1991) 1.09
Purified mu EBP-E binds to immunoglobulin enhancers and promoters. Mol Cell Biol (1988) 1.09
A plasmacytoma-specific factor binds the c-myc promoter region. Proc Natl Acad Sci U S A (1987) 1.09
TFE3 contains two activation domains, one acidic and the other proline-rich, that synergistically activate transcription. Nucleic Acids Res (1995) 1.08
Aggression and fighting behavior among African-American adolescents: individual and family factors. Am J Public Health (1994) 1.07
The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression. Nucleic Acids Res (1997) 1.04
Intravenous treatment of hypokalemic periodic paralysis. Arch Neurol (1983) 1.01
Uterine hyperstimulation. The need for standard terminology. J Reprod Med (1987) 1.00
YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci U S A (1996) 0.99
Escherichia coli single-strand DNA binding protein from wild type and lexC113 mutant affects in vitro proteolytic cleavage of phage lambda repressor. Proc Natl Acad Sci U S A (1982) 0.97
Two types of DNA rearrangements in immunoglobulin genes. Cold Spring Harb Symp Quant Biol (1981) 0.96
Translocation affects normal c-myc promoter usage and activates fifteen cryptic c-myc transcription starts in plasmacytoma M603. Nucleic Acids Res (1984) 0.96
Interaction of single-strand binding protein and RecA protein at the single-stranded DNA site. J Mol Biol (1983) 0.94
The C/EBP family of proteins distorts DNA upon binding but does not introduce a large directed bend. J Biol Chem (1994) 0.93
Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J Immunol (1998) 0.92
Documentation of inpatient experiences of resident physicians. J Med Educ (1985) 0.89
Characterization of activated and normal mouse Mos gene in murine 3T3 cells. Oncogene (1992) 0.89
An active chromatin structure acquired by translocated c-myc genes. Mol Cell Biol (1986) 0.86
Inhibition of v-Abl transformation by p53 and p19ARF. Oncogene (1999) 0.85
Physical location of ribosome binding sites on lambda DNA. J Mol Biol (1977) 0.84
Visualization of ribosome--single-stranded DNA complexes in the electron microscope. Biochemistry (1977) 0.83
Correlation between UV dose requirement for lambda bacteriophage induction and lambda repressor concentration. J Virol (1978) 0.82
Strong transcriptional activation of translocated c-myc genes occurs without a strong nearby enhancer or promoter. Nucleic Acids Res (1988) 0.82
Retention of court-referred adolescents and young adults in the therapeutic community. Am J Drug Alcohol Abuse (1987) 0.81
Role of B-lymphocyte-induced maturation protein-1 in terminal differentiation of B cells and other cell lineages. Cold Spring Harb Symp Quant Biol (1999) 0.81
Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes. Prog Clin Biol Res (1990) 0.81
Rationale for Chinese gauze masks? N Engl J Med (1973) 0.81
Central hemangioma of the maxilla. J Oral Surg (1972) 0.80
p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo. Mol Cell Biol (2000) 0.79
A 125 bp region of the Ig VH1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice. Int Immunol (1996) 0.79
Genetic analyses of tattered, an X-linked dominant, developmental mouse mutation. Mamm Genome (1995) 0.79
Effect of pheochromocytoma and hypophysectomy on blood pressure and catecholamines in NEDH rats. Hypertension (1982) 0.78
Patterns of uterine contractions and prolonged uterine activity using three methods of breast stimulation for contraction stress tests. Obstet Gynecol (1989) 0.77
Cobalt: an effector of E. coli recA protein activity. Nucleic Acids Res (1982) 0.77
v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts. Oncogene (2000) 0.77
Location of ribosome-binding sites on the tetracycline resistance transposon Tn10. J Bacteriol (1978) 0.76